^
Association details:
Biomarker:No biomarker
Cancer:Ovarian Cancer
Drug:exemestane (Aromatase inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Ovarian cancer /Fallopian Tube cancer/Primary Peritoneal cancer: Preferred Regimens...Hormone therapy (aromatase inhibitors: anastrozole, letrozole, exemestane) (category 2B).